Anticancer properties of bee venom bioactive compounds: a scoping review

Abdul Rahim, Siti Nur Farisyah and Abdull Rasad, Mohammad Syaiful Bahari (2025) Anticancer properties of bee venom bioactive compounds: a scoping review. International Journal of Allied Health Sciences, 9 (Supp 3). pp. 411-420. E-ISSN 2600-8491

PDF - Published Version Restricted to Repository staff only Download (506kB) | Request a copy

Abstract

Background: Apis melliferra (bee venom) has long been used in alternative medicine for its therapeutic effects and recently research highlights its anticancer potential. This scoping review aims to systematically gather and evaluate evidence on the anticancer properties of bee venom and its bioactive compounds. Methods: This review followed PRISMA-ScR guidelines using articles retrieved from PubMed, ScienceDirect and Scopus from 2010 to 2024. Studies were screened based on inclusion and exclusion criteria, focusing on the anticancer effects of bee venom components. A total of 240 articles were retrieved, with 35 meeting the eligibity criteria. Data on cancer type, model, compound, and mechanism were extracted and analyzed. Results: It was found that melittin was the most frequently investigated compound, showing anticancer activity in breast, lung, glioblastoma, and ovarian cancer models. Mechanisms include induction of apoptosis, inhibition of cell proliferation, suppression of NFκB and PI3K/Akt/mTOR pathways, and modulation of immune responses. Additionally, a number of studies documented synergistic effects when melittin was mixed with apamin and PLA2, two additional components of bee venom. Conclusion: Bee venom, particularly melittin, demonstrated strong anticancer potential by targeting multiple molecular pathways. However, further in vivo and clinical studies are required to validate its efficacy and safety as a therapeutic agent in addition to thorough examination of less well-known substances such as adolapin and MCD peptide.

Item Type:	Article (Review)
Uncontrolled Keywords:	Bee venom, anticancer activity, melittin, bioactive compounds
Subjects:	Q Science > Q Science (General)
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Allied Health Sciences Kulliyyah of Allied Health Sciences > Department of Biomedical Science (Effective:1st July 2011)
Depositing User:	Dr. Mohammad Syaiful Bahari Abdull Rasad
Date Deposited:	29 Dec 2025 13:05
Last Modified:	29 Dec 2025 13:05
Queue Number:	2025-12-Q1358
URI:	http://irep.iium.edu.my/id/eprint/126496

Actions (login required)

View Item